Skip to main content
Log in

Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder

  • Original paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Three patients with psychoses and concomitant prolactin-secreting pituitary tumours are described. Patients A and B had bipolar and schizoaffective disorders, respectively. They had both been treated with neuroleptics for 20 years before the prolactinomas were revealed. Patient C developed a paranoid psychosis after two years of continuous bromocriptine treatment for a pituitary tumour. In patient A the prolactin level was successfully normalized and a good antipsychotic effect was maintained by combined therapy with haloperidol and quinagolide but not bromocriptine. In patient B the prolactinoma was removed by surgery, in view of the serious nature of the psychotic disorder, to avoid psychotic relapse by treatment with a dopamine agonist. In patient C a good result was obtained with the combination of clozapine and bromocriptine. These case reports support the view that neuroleptics being dopamine antagonists and dopamine agonistic agents which are the primary treatment of prolactinomas can cancel out each other’s effects. The combination of clozapine and quinagolide is recommended as the treatment of choice for most patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 17 March 1998 / Accepted: 20 October 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melkersson, K., Hulting, AL. Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder. European Archives of Psychiatry and Clinical Neurosciences 250, 6–10 (2000). https://doi.org/10.1007/PL00007539

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00007539

Navigation